Brand · Tablet · Updated Nov 11, 2026
Subvenite 100 mg tablet price what pharmacies pay, and what you should
Is my price fair?
Check the price you were quoted
Type what the pharmacy asked for subvenite 100 mg tablet and see the markup over what they pay.
A benchmark from public data, not a price offer or medical advice. Prices vary by pharmacy, insurance and discount programs.
Subvenite 100 mg price history
What pharmacies pay for 30 tablets, weekly- Now
- $1.45
- 52-week low
- $1.32
- 52-week high
- $1.46
- A year ago
- $1.38
Why the price changed
| Effective | Before | After | Change | Reason |
|---|---|---|---|---|
| Oct 21, 2026 | $0.0487 | $0.0483 | -0.8% | pharmacies' invoice prices changed (survey) |
| Sep 23, 2026 | $0.0487 | $0.0487 | No change | pharmacies' invoice prices changed (survey) |
| Aug 19, 2026 | $0.0478 | $0.0487 | +2.1% | pharmacies' invoice prices changed (survey) |
| Jul 22, 2026 | $0.0468 | $0.0478 | +2.0% | pharmacies' invoice prices changed (survey) |
| Jun 17, 2026 | $0.0456 | $0.0468 | +2.8% | pharmacies' invoice prices changed (survey) |
| May 20, 2026 | $0.0445 | $0.0456 | +2.3% | pharmacies' invoice prices changed (survey) |
| Apr 22, 2026 | $0.0441 | $0.0445 | +0.9% | pharmacies' invoice prices changed (survey) |
| Mar 18, 2026 | $0.0441 | $0.0441 | +0.1% | pharmacies' invoice prices changed (survey) |
Prices per tablet. Reasons are the ones the national survey gives: a survey rate change comes from pharmacies' own invoices; a published price change follows the maker's list price.
What people paid for subvenite 100 mg tablet
What did your pharmacy charge? It takes 30 seconds, it's anonymous - and it shows everyone which pharmacies are fair.
Supply status: shortages & recalls
Shortages
- Lamotrigine, Tablet, Extended Release, 100 mg (NDC 49884-563-11)Discontinuation of the manufacture of the drug
- Lamotrigine, Tablet, Extended Release, 25 mg (NDC 49884-561-11)Discontinuation of the manufacture of the drug
- Lamotrigine, Tablet, Extended Release, 250 mg (NDC 49884-604-11)Discontinuation of the manufacture of the drug
- Lamotrigine, Tablet, Extended Release, 300 mg (NDC 49884-605-11)Discontinuation of the manufacture of the drug
- Lamotrigine, Tablet, Extended Release, 50 mg (NDC 49884-562-11)Discontinuation of the manufacture of the drug
- Lamotrigine, Tablet, Extended Release, 200 mg (NDC 49884-564-11)Discontinuation of the manufacture of the drug
In a shortage, ask your pharmacist whether another strength, form or maker is in stock, and how much notice they need. What to do in a drug shortage.
Recalls
Showing the 6 most relevant of 13 - all recalls.
A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.
Every manufacturer and package code
1 company sell subvenite 100 mg tablet under 1 package code (NDC).
| Maker | Package codes | Per unit |
|---|---|---|
| OWP Pharmaceuticals, Inc. | 69102-319-01 | $0.0483 |
All 1 package codes
A dash means no weekly price for that maker's packages. Which maker your pharmacy stocks usually doesn't change what you pay, but you can ask.
The generic costs about the same
Questions to ask your pharmacist
- "Is the generic right for me?" The generic, lamotrigine 100 mg tablet, costs pharmacies $1.45 for 30 tablets.
- "What is your cash price, without insurance?" For low-cost generics it can be less than a copay.
- "Is a 90-day supply cheaper per tablet?" Dispensing fees are charged per fill, so fewer fills often cost less.
- "Would 25 mg tablet work for me instead?" Pharmacies pay $0.0270 per tablet for it, against $0.0483 for this one. Only your prescriber can say whether a different strength or form suits you.
- "Do you match other pharmacies or accept discount cards?" Many do, if you ask.
These are questions, not advice. Never change how you take a medicine without talking to your prescriber or pharmacist.
Other subvenite strengths and forms
| Strength and form | Per unit | Pharmacies pay | ||
|---|---|---|---|---|
| 10 mg/mL oral suspension Brand | $2.86 | $687.43 / 240 mL | ||
| Orange (for patients not taking carbamazepine, phenytoin, phenobarbital, primidone, or valproate) pack Brand | Not priced this week | |||
| 25 mg tablet Brand | $0.0270 | $0.81 / 30 tablets | ||
| 150 mg tablet Brand | $0.0688 | $2.06 / 30 tablets | ||
| 200 mg tablet Brand | $0.0801 | $2.40 / 30 tablets | ||
Official label & what changed
These highlights do not include all the information needed to use SUBVENITE® safely and effectively. See full prescribing information for SUBVENITE®.SUBVENITE (lamotrigine) oral suspensionInitial U.S. Approval: 1994
WARNING: SERIOUS SKIN RASHES
SUBVENITE can cause serious rashes requiring hospitalization and discontinuation of treatment. The incidence of these rashes, which have included Stevens-Johnson syndrome, is approximately 0.3% to 0.8% in pediatric patients (aged 2 to 17 years) and 0.08% to 0.3% in adults receiving lamotrigine. One rash-related death was reported in a prospectively followed cohort of 1,983 pediatric patients (aged 2 to 16 years) with epilepsy taking lamotrigine as adjunctive therapy. In worldwide postmarketing experience, rare cases of toxic epidermal necrolysis and/or rash-related death have been reported in adult and pediatric patients, but their numbers are too few to permit a precise estimate of the rate.
In addition to age, factors that may increase the risk of occurrence or the severity of rash caused by lamotrigine include (1) coadministration of lamotrigine with valproate (includes valproic acid and divalproex sodium), (2) exceeding the recommended initial dose of SUBVENITE, (3) exceeding the recommended dose escalation for SUBVENITE, or (4) the presence of the HLA-B*1502 allele. However, cases have occurred in the absence of these factors.
Nearly all cases of life-threatening rashes caused by lamotrigine have occurred within 2 to 8 weeks of treatment initiation. However, isolated cases have occurred after prolonged treatment (e.g., 6 months). Accordingly, duration of therapy cannot be relied upon as means to predict the potential risk heralded by the first appearance of a rash.
Although benign rashes are also caused by lamotrigine, it is not possible to predict reliably which rashes will prove to be serious or life threatening. Accordingly, SUBVENITE should ordinarily be discontinued at the first sign of rash, unless the rash is clearly not drug related. Discontinuation of treatment may not prevent a rash from becoming life threatening or permanently disabling or disfiguring [see Warnings and Precautions (5.1)].
WARNING: SERIOUS SKIN RASHES
See full prescribing information for complete boxed warning.
Cases of life-threatening serious rashes, including Stevens-Johnson syndrome and toxic epidermal necrolysis, and/or rash-related death have been caused by lamotrigine, the active ingredient in SUBVENITE. The rate of serious rash is greater in pediatric patients than in adults. Additional factors that may increase the risk of rash include:
coadministration with valproate.
exceeding recommended initial dose of SUBVENITE.
exceeding recommended dose escalation for SUBVENITE.
presence of the HLA-B*1502 allele. (5.1)
Benign rashes are also caused by lamotrigine, the active ingredient in SUBVENITE; however, it is not possible to predict which rashes will prove to be serious or life threatening. SUBVENITE should be discontinued at the first sign of rash, unless the rash is clearly not drug related. (5.1)
Recent major changes (as listed on the label)
Boxed Warning | 08/2026 |
Warnings and Precautions (5.1) | 08/2026 |
Warnings and Precautions (5.4) | 08/2026 |
We check this label every day. When it changes, the sections that changed appear here, old text beside new.
We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.
Questions about subvenite 100 mg tablet
How much does subvenite 100 mg tablet cost without insurance?
Pharmacies pay about $1.45 for 30 tablets ($0.0483 per tablet) as of November 11, 2026. A fair cash price is about $12.17: that cost plus a 15% margin and a $10.50 dispensing fee. Online cost-plus pharmacies charge around $11.67 including shipping.
Is my price for subvenite 100 mg tablet fair?
Compare it with the fair cash price of $12.17 for 30 tablets. Up to about $15.21 is fair; above $24.34 is high, and worth asking the pharmacy for its cash price or trying another pharmacy. Check your quote.
Is subvenite 100 mg tablet getting more expensive?
Over the last four weeks the price pharmacies pay fell 0.8%. Over a year it rose 5.4%. See the 52-week chart.
Is there a cheaper generic of Subvenite 100 mg tablet?
Yes: lamotrigine 100 mg tablet, which pharmacies get for $1.45 for the same amount.
Who makes subvenite 100 mg tablet?
1 company: OWP Pharmaceuticals, Inc.. See every package code.
Is subvenite in shortage?
Yes - 6 products are listed as short or being discontinued. Details.
Has subvenite been recalled?
13 recalls on record. Recalls name specific lots - check yours.
What does "pharmacies pay" mean?
It's the national average price retail pharmacies pay wholesalers and makers to buy the drug, from a weekly government survey of pharmacy invoices. It doesn't include the pharmacy's costs of filling a prescription, which is why the fair price adds a margin and a dispensing fee. How we work it out.
Talk about subvenite 100 mg tablet
No comments yet. Questions, tips, what worked for you - start the conversation.